Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Neuropeptide S (NPS)
NP-S
- Product No.CEA796Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range12.35-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 4.43pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 392
For more details, please contact local distributors! US$ 560 US$ 2520 US$ 4760 US$ 39200
Specificity
This assay has high sensitivity and excellent specificity for detection of Neuropeptide S (NPS).
No significant cross-reactivity or interference between Neuropeptide S (NPS) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Neuropeptide S (NPS) and the recovery rates were calculated by comparing the measured value to the expected amount of Neuropeptide S (NPS) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 87-97 | 93 |
EDTA plasma(n=5) | 89-102 | 96 |
heparin plasma(n=5) | 92-102 | 97 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Neuropeptide S (NPS) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Neuropeptide S (NPS) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Neuropeptide S (NPS) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 80-96% | 96-103% | 87-95% | 87-101% |
EDTA plasma(n=5) | 93-101% | 90-99% | 95-105% | 82-97% |
heparin plasma(n=5) | 79-88% | 92-105% | 92-104% | 84-98% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Nordic Journal of Psychiatry | Investigating the relationship between plasma neuropeptide-S levels and clinical depression Pubmed:29488437 |
Archives of Neuropsychiatry | Plasma Neuropeptide-S Levels in Populations Diagnosed with Generalized Anxiety Disorder: A Controlled Study. |
Neurological Sciences | The effects of IVIg therapy on serum levels of neuropeptide Y and cytokines in Guillain-Barré syndrome Pubmed: 31494821 |
Respiratory Physiology & Neurobiology | Effects of nanoparticles on Neuroinflammation in a Mouse Model of Asthma Pubmed: 31542455 |
Neuroscience | Role of Neuropeptide S on behavioural and neurochemical changes of an animal model of attention-deficit/hyperactivity disorder Pubmed: 32976984 |
Sci Transl Med | Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis 34433639 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA796Hu01 | Recombinant Neuropeptide S (NPS) | Positive Control; Immunogen; SDS-PAGE; WB. |
SPA796Hu01 | Synthetic Neuropeptide S (NPS) | Immunogen; Blocking Peptide. |
CPA796Hu21 | OVA Conjugated Neuropeptide S (NPS) | Immunogen; SDS-PAGE; WB. |
PAA796Hu01 | Polyclonal Antibody to Neuropeptide S (NPS) | WB; IHC; ICC; IP. |
LAA796Hu71 | Biotin-Linked Polyclonal Antibody to Neuropeptide S (NPS) | WB; IHC; ICC. |
MAA796Hu22 | Monoclonal Antibody to Neuropeptide S (NPS) | WB; IHC; ICC; IP. |
CEA796Hu | ELISA Kit for Neuropeptide S (NPS) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA796Hu | Multiplex Assay Kit for Neuropeptide S (NPS) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
KSA796Hu11 | ELISA Kit DIY Materials for Neuropeptide S (NPS) | Main materials for "Do It (ELISA Kit) Yourself". |